APA (7th ed.) Citation

ML, Y., C, B., EL, F., EM, Y., C, T., CH, L., . . . SC, C. (2026). Benefit of Salbutamol for the Treatment of Neuromuscular Junction Dysfunction in Patients With Purine-Rich Element Binding Protein A (PURA) Syndrome. Cureus, 18(7), e112808. https://doi.org/10.7759/cureus.112808

Chicago Style (17th ed.) Citation

ML, Yau, et al. "Benefit of Salbutamol for the Treatment of Neuromuscular Junction Dysfunction in Patients With Purine-Rich Element Binding Protein A (PURA) Syndrome." Cureus 18, no. 7 (2026): e112808. https://doi.org/10.7759/cureus.112808.

MLA (9th ed.) Citation

ML, Yau, et al. "Benefit of Salbutamol for the Treatment of Neuromuscular Junction Dysfunction in Patients With Purine-Rich Element Binding Protein A (PURA) Syndrome." Cureus, vol. 18, no. 7, 2026, p. e112808, https://doi.org/10.7759/cureus.112808.